Therapeutic potential of hydrogen-rich water (HRW) in oxidative stress-related diseases.
Wafaa H Mohamed, Idris Long · Journal of clinical biochemistry and nutrition · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the mechanistic basis, experimental evidence, and clinical applicability of hydrogen-rich water (HRW) in oxidative stress-related diseases. Evidence supporting the safety of inhalational H₂ exposure derives from toxicological and clinical studies rather than regulatory GRAS (70). Preclinical safety assessments further support this profile; rodents administered molecular H₂ at doses up to 10 mg H₂ /kg/day exhibited no mortality, organ toxicity, behavioural abnormalities, or histopathological alterations, indicating an exceptionally wide safety margin for systemic exposure (71). Consistent findings have been reported in human studies, where daily intake of 0.3–1.2 L of HRW containing approximately 0.6–1.6 ppm dissolved H₂ over periods of 4–12 weeks resulted in no clinically meaningful changes in liver enzymes, renal function markers, hematologic indices, or electrocardiographic parameters (13). A practical consideration for clinical and consumer use is H₂ ’s rapid diffusion and volatility, which leads to measurable decline in dissolved concentration when water is left unsealed or exposed to agitation (44, 47). fresh preparation, sealed pressurized packaging, or certified storage vessels are required to maintain therapeutic concentrations (44). Standardized HRW production methods such as electrolytic generators, pressurized filling systems, and magnesium-based effervescent tablet reactions have been shown to yield reproducible H₂ concentrations when validated with dissolved H₂ meters and controlled preparation protocols (42, 44, 45). Both continuous daily intake and intermittent consumption schedules have demonstrated physiological effects across clinical studies, suggesting that H₂ ’s biological activity is mediated via transient redox signalling modulation rather than cumulative tissue accumulation, with benefits generally sustained during regular intake and diminishing gradually after discontinuation. ( 13, 64, 65 ). Due to substantial methodological heterogeneity, findings were synthesized qualitatively. due to heterogeneity in dosing strategies, biomarker selection, and outcome reporting. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. Evidence supporting the safety of inhalational H₂ exposure derives from toxicological and clinical studies rather than regulatory GRAS (70). Preclinical safety assessments further support this profile; rodents administered molecular H₂ at doses up to 10 mg H₂ /kg/day exhibited no mortality, organ toxicity, behavioural abnormalities, or histopathological alterations, indicating an exceptionally wide safety margin for systemic exposure (71). Consistent findings have been reported in human studies, where daily intake of 0.3–1.2 L of HRW containing approximately 0.6–1.6 ppm dissolved H₂ over periods of 4–12 weeks resulted in no clinically meaningful changes in liver enzymes, renal function markers, hematologic indices, or electrocardiographic parameters (13). A practical consideration for clinical and consumer use is H₂ ’s rapid diffusion and volatility, which leads to measurable decline in dissolved concentration when water is left unsealed or exposed to agitation (44, 47). Therefore, fresh preparation, sealed pressurized packaging, or certified storage vessels are required to maintain therapeutic concentrations (44). Standardized HRW production methods such as electrolytic generators, pressurized filling systems, and magnesium-based effervescent tablet reactions have been shown to yield reproducible H₂ concentrations when validated with dissolved H₂ meters and controlled preparation protocols (42, 44, 45). Both continuous daily intake and intermittent consumption schedules have demonstrated physiological effects across clinical studies, suggesting that H₂ ’s biological activity is mediated via transient redox signalling modulation rather than cumulative tissue accumulation, with benefits generally sustained during regular intake and diminishing gradually after discontinuation. ( 13, 64, 65 ).
What the Researchers Studied
The authors reviewed the mechanistic basis, experimental evidence, and clinical applicability of hydrogen-rich water (HRW) in oxidative stress-related diseases.
What Effects Did Molecular Hydrogen Have?
Evidence supporting the safety of inhalational H₂ exposure derives from toxicological and clinical studies rather than regulatory GRAS (70). Preclinical safety assessments further support this profile; rodents administered molecular H₂ at doses up to 10 mg H₂ /kg/day exhibited no mortality, organ toxicity, behavioural abnormalities, or histopathological alterations, indicating an exceptionally wide safety margin for systemic exposure (71). Consistent findings have been reported in human studies, where daily intake of 0.3–1.2 L of HRW containing approximately 0.6–1.6 ppm dissolved H₂ over periods of 4–12 weeks resulted in no clinically meaningful changes in liver enzymes, renal function markers, hematologic indices, or electrocardiographic parameters (13). A practical consideration for clinical and consumer use is H₂ ’s rapid diffusion and volatility, which leads to measurable decline in dissolved concentration when water is left unsealed or exposed to agitation (44, 47). Therefore, fresh preparation, sealed pressurized packaging, or certified storage vessels are required to maintain therapeutic concentrations (44). Standardized HRW production methods such as electrolytic generators, pressurized filling systems, and magnesium-based effervescent tablet reactions have been shown to yield reproducible H₂ concentrations when validated with dissolved H₂ meters and controlled preparation protocols (42, 44, 45). Both continuous daily intake and intermittent consumption schedules have demonstrated physiological effects across clinical studies, suggesting that H₂ ’s biological activity is mediated via transient redox signalling modulation rather than cumulative tissue accumulation, with benefits generally sustained during regular intake and diminishing gradually after discontinuation. ( 13, 64, 65 ). The authors concluded that due to substantial methodological heterogeneity, findings were synthesized qualitatively. A structured literature search identified mechanistic, preclinical, and clinical studies investigating HRW or molecular hydrogen (H₂) on oxidative stress, inflammation, mitochondrial regulation, and disease-related outcomes.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
Reported limitations: Due to substantial methodological heterogeneity, findings were synthesized qualitatively. due to heterogeneity in dosing strategies, biomarker selection, and outcome reporting. Evidence supporting the safety of inhalational H₂ exposure derives from toxicological and clinical studies rather than regulatory GRAS (70). Preclinical safety assessments further support this profile; rodents administered molecular H₂ at doses up to 10 mg H₂ /kg/day exhibited no mortality, organ toxicity, behavioural abnormalities, or histopathological alterations, indicating an exceptionally wide safety margin for systemic exposure (71). Consistent findings have been reported in human studies, where daily intake of 0.3–1.2 L of HRW containing approximately 0.6–1.6 ppm dissolved H₂ over periods of 4–12 weeks resulted in no clinically meaningful changes in liver enzymes, renal function markers, hematologic indices, or electrocardiographic parameters (13). A practical consideration for clinical and consumer use is H₂ ’s rapid diffusion and volatility, which leads to measurable decline in dissolved concentration when water is left unsealed or exposed to agitation (44, 47). fresh preparation, sealed pressurized packaging, or certified storage vessels are required to maintain therapeutic concentrations (44). Standardized HRW production methods such as electrolytic generators, pressurized filling systems, and magnesium-based effervescent tablet reactions have been shown to yield reproducible H₂ concentrations when validated with dissolved H₂ meters and controlled preparation protocols (42, 44, 45). Both continuous daily intake and intermittent consumption schedules have demonstrated physiological effects across clinical studies, suggesting that H₂ ’s biological activity is mediated via transient redox signalling modulation rather than cumulative tissue accumulation, with benefits generally sustained during regular intake and diminishing gradually after discontinuation. ( 13, 64, 65 ). Across all categories, clinical research on HRW remains limited by recurring methodological constraints.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.